Condrosulf, Chondroitin
Chondroitin is a substance that occurs naturally in the connective tissues of people and animals. As a supplement in higher doses than is found naturally, chondroitin is a popular treatment for osteoarthritis.
- Origin: Synthetic, bacterial-fermentation
- Source: Bacteria
- Type: Carbohydrates
- Age Range: Adults
- Toxicity: There is no evidence of toxicity until now
- Outcomes: Bone and Joint Health, Joint Inflammatory and Stiffness
What are Chondroitin benefits?
Chondroitin is a supplement often used in conjunction with glucosamine to help treat joint pain and stiffness and other symptoms of osteoarthritis (OA). However, although many people report some benefits from using chondroitin, (especially when combined with glucosamine), scientific researchers do not hold these two supplements in high regard for treating osteoarthritis symptoms.
Table of relations
Chondroitin and Bone and Joint Health
-
Joint Inflammatory and Stiffness
Joint stiffness and inflammation is the feeling of limited joint movement. This sensation may or may not be caused by weakness and is associated with long periods of immobility. Stiffness is common with arthritis, and inflammation worsens the pain and limits certain movement. The timing and cause of the inflammation and stiffness can only be diagnosed by doctors, but preventive and palliative treatments are options for those who suffer from these complaints.
Table of negative interactions
Related videos about Chondroitin
References
- ^ ANALYSIS OF MATRIX GLYCOSAMINOGLYCANS (GAGS) IN URINARY STONES BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY.
- ^ a b Conte A, et al. Biochemical and pharmacokinetic aspects of oral treatment with chondroitin sulfate. Arzneimittelforschung. (1995)
- ^ Schiraldi C, Cimini D, De Rosa M. Production of chondroitin sulfate and chondroitin. Appl Microbiol Biotechnol. (2010)
- ^ Conte A, et al. Metabolic fate of exogenous chondroitin sulfate in man. Arzneimittelforschung. (1991)
- ^ a b Volpi N. Oral bioavailability of chondroitin sulfate (Condrosulf) and its constituents in healthy male volunteers. Osteoarthritis Cartilage. (2002)
- ^ a b c Jackson CG1, et al. The human pharmacokinetics of oral ingestion of glucosamine and chondroitin sulfate taken separately or in combination. Osteoarthritis Cartilage. (2010)
- ^ Ronca G, Conte A. Metabolic fate of partially depolymerized shark chondroitin sulfate in man. Int J Clin Pharmacol Res. (1993)
- ^ Deal CL, Moskowitz RW. Nutraceuticals as therapeutic agents in osteoarthritis. The role of glucosamine, chondroitin sulfate, and collagen hydrolysate. Rheum Dis Clin North Am. (1999)
- ^ Bruyere O, Reginster JY. Glucosamine and chondroitin sulfate as therapeutic agents for knee and hip osteoarthritis. Drugs Aging. (2007)
- ^ Black C, et al. The clinical effectiveness of glucosamine and chondroitin supplements in slowing or arresting progression of osteoarthritis of the knee: a systematic review and economic evaluation. Health Technol Assess. (2009)
- ^ a b Wandel S, et al. Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis. BMJ. (2010)
- ^ Reichenbach S, et al. Meta-analysis: chondroitin for osteoarthritis of the knee or hip. Ann Intern Med. (2007)
- ^ a b McAlindon TE, et al. Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis. JAMA. (2000)